Transdermal Diagnostics

Provider of a needle-free continuous glucose monitoring device

placeBath, England, United Kingdom calendar_todayFounded 2021 groups2 employees language transdermal-diagnostics.com

Registered entities

Innovation

3 patent families (2 granted) — focus: Human necessities; filing pace accelerating. Cited 16 times.

YearFilings
20231
20242
20252
20261

Social engagement

Social engagement: 3.4K social following, 3 posts in the last 12 months — around the industry typical range.

Investor mix

28 investors on record; lead investors include Qubis.

Investor typeCountShare
Venture capital414%
Angel & family office14%
Accelerator & incubator14%
Other / undisclosed2279%

Recent activity

19 Sep 2025
Recognition
27 Aug 2025
Product launch
GlucoPatch-24 sensor
Coming soon